Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan W Drijfhout

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Immunological Reviews|October 14, 2017
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillanceNorma Bloy, Pauline Garcia, Céline M Laumont, et al.
Nature Immunology|January 17, 2012
Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetesAnna M Bulek, David K Cole, Ania Skowera, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2006
DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotypeIvana Durinovic-Belló, Silke Rosinger, Jennifer A Olson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccineMarij J P Welters, Gemma G Kenter, Sytse J Piersma, et al.
Arthritis Research & Therapy|September 4, 2021
Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational loadSanne Reijm, Theresa Kissel, Gerrie Stoeken-Rijsbergen, et al.
European Journal of Immunology|May 15, 2010
Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaquesMaximillian Rosario, Anne Bridgeman, Esther D Quakkelaar, et al.
International Journal of Cancer|September 6, 2012
Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trialEliane C M Zeestraten, Frank M Speetjens, Marij J P Welters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancerFrank M Speetjens, Peter J K Kuppen, Marij J P Welters, et al.
Oncoimmunology|April 11, 2018
Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trialHansje-Eva Teulings, Esther P M Tjin, Karina J Willemsen, et al.
International Journal of Cancer|July 22, 2009
Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trialNinke Leffers, Annechien J A Lambeck, Marloes J M Gooden, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Immunological Reviews|October 14, 2017
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillanceNorma Bloy, Pauline Garcia, Céline M Laumont, et al.
Nature Immunology|January 17, 2012
Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetesAnna M Bulek, David K Cole, Ania Skowera, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2006
DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotypeIvana Durinovic-Belló, Silke Rosinger, Jennifer A Olson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccineMarij J P Welters, Gemma G Kenter, Sytse J Piersma, et al.
Arthritis Research & Therapy|September 4, 2021
Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational loadSanne Reijm, Theresa Kissel, Gerrie Stoeken-Rijsbergen, et al.
European Journal of Immunology|May 15, 2010
Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaquesMaximillian Rosario, Anne Bridgeman, Esther D Quakkelaar, et al.
International Journal of Cancer|September 6, 2012
Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trialEliane C M Zeestraten, Frank M Speetjens, Marij J P Welters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancerFrank M Speetjens, Peter J K Kuppen, Marij J P Welters, et al.
Oncoimmunology|April 11, 2018
Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trialHansje-Eva Teulings, Esther P M Tjin, Karina J Willemsen, et al.
International Journal of Cancer|July 22, 2009
Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trialNinke Leffers, Annechien J A Lambeck, Marloes J M Gooden, et al.
Pageof 14